Dr Davide Bedognetti presents at ecancer's Milan Summit on Precision Medicine 2018 about immune responsiveness in cancer.
He discusses the genetic determinants behind this, touching upon the Immunologic Constant of Rejection (ICR) pathways and genes involved.
The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine